News & Updates

Polygenic risk scores (PRS) for bipolar disorder, major depression, and schizophrenia are predictive of episode polarity and psychotic symptoms in a similar manner among individuals with bipolar disorder, suggests a recent study.

Supplementation with vitamin E fixes the intestinal barrier and the gastrointestinal tract, which then helps prevent and treat rheumatoid arthritis (RA), reveals a study.

When added to standard treatment, mindfulness-based cognitive therapy (MBCT) may have favourable effects for patients with bipolar disorder and moderate to severe levels of depression and functional impairment, according to a study.

One in six people with poorly controlled type 2 diabetes (T2D) in Singapore experiences diabetes distress, with the risk factors including younger age, previous tobacco use, kidney disease history, and depressive symptoms, as reported in a study.

The beneficial effect of moderate alcohol consumption in preventing depression appears causal, suggest the results of a recent study.

A novel once-a-day inhaler for asthma that contains a fixed-dose combination of the corticosteroid mometasone furoate (MF), the long-acting beta-agonist indacaterol acetate (IND), and the long-acting muscarinic antagonist glycopyrronium bromide (GLY) appears to have a favourable effect in patients with persistent airflow limitation (PAL), according to a post hoc analysis of the IRIDIUM study.